Kaneez Fatima
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kaneez Fatima has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Muhammad Mukhlis
Ayub Medical College, Abbottabad, Pakistan
4 shared publications - Sadia Qazi
College of Medicine, Alfaisal University
4 shared publications - Vishan Das
Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
4 shared publications - Eshal Atif
College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
3 shared publications - Muhammad Atif Mazhar
Department of Anatomy, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
3 shared publications - Abdul Moeez Awais
Islamic International Medical College, Riphah International University, Rawalpindi, Pakistan
2 shared publications
Latest Publications
- Open Access
- 8 October 2026
- Published by Springer Nature in BMC Pulmonary Medicine
Temporal trends in mortality associated with chronic lower respiratory disease and dementia: evidence from CDC WONDER, 1999–2023
Introduction: Chronic lower respiratory disease (CLRD) and dementia are the leading causes of death among older US adults and frequently coexist; however, their combined mortality burden is uncharacterized nationally. We examined the trends and disparities in deaths involving both. Methods: We analyzed 1999–2023 US multiple cause-of-death data from the CDC WONDER for decedents aged ≥ 65 years with both CLRD (ICD-10 J40–J47) and dementia (F01, F03, G30–G31) listed anywhere on the certificate. Age-adjusted mortality rates (AAMRs) per 100,000 were calculated overall and by sex, race/ethnicity, census region, urbanization, and place of death; crude rates (CMRs) were used for age strata. Joinpoint regression gave annual and average annual percent changes (APCs, AAPCs). Results: Among 557,547 deaths, the overall AAMR rose from 29.50 per 100,000 in 1999 to 55.69 in 2023, peaking at 65.70 in 2020 (AAPC: 2.64; 95% CI: 0.93–4.39; p = 0.002). Men had a higher mean AAMR than women (57.58 vs. 47.29), but only women rose significantly (AAPC: 3.66; p < 0.001 vs. 1.42; p = 0.128); the male-to-female ratio fell from 1.62 to 0.97, with women overtaking men by 2023. The mean AAMRs were 55.07 in non-Hispanic (NH) White (AAPC: 3.02; p = 0.0004), 40.56 in NH Black (2.70; p = 0.035), 32.47 in Hispanic (1.20; p = 0.001), and 20.42 in NH Asian or Pacific Islander adults (3.13; p = 0.206); and 55.18 in the South (2.80; p < 0.001), 54.84 in the Midwest (3.02; p = 0.004), 51.19 in the West (2.53; p = 0.005), and 39.60 in the Northeast (1.91; p = 0.065). Non-metropolitan AAMRs exceeded metropolitan AAMRs (61.70 vs. 47.61; AAPC: 4.12; p < 0.001 vs. 2.85; p = 0.008), with the gap widening from 5.0 to 22.6. 2023 CMRs were 243.83 (≥ 85 years; AAPC: 3.19; p = 0.001), 59.36 (75–84; 2.38; p = 0.011) and 8.98 (65–74; 2.80; p = 0.019). Nursing home deaths fell from 58.2% to 43.3% as home deaths rose to 28.0% and hospice deaths to 7.9%. Conclusion: Mortality involving coexisting CLRD and dementia in older US adults nearly doubled from 1999 to 2023, shifting toward women, non-metropolitan residents, and the very old, while end-of-life care moved from hospitals and nursing homes into homes and hospices.
- 8 October 2026
- Published by Springer Nature in BMC Pulmonary Medicine
Open AccessTemporal trends in mortality associated with chronic lower respiratory disease and dementia: evidence from CDC WONDER, 1999–2023
Introduction: Chronic lower respiratory disease (CLRD) and dementia are the leading causes of death among older US adults and frequently coexist; however, their combined mortality burden is uncharacterized nationally. We examined the trends and disparities in deaths involving both. Methods: We analyzed 1999–2023 US multiple cause-of-death data from the CDC WONDER for decedents aged ≥ 65 years with both CLRD (ICD-10 J40–J47) and dementia (F01, F03, G30–G31) listed anywhere on the certificate. Age-adjusted mortality rates (AAMRs) per 100,000 were calculated overall and by sex, race/ethnicity, census region, urbanization, and place of death; crude rates (CMRs) were used for age strata. Joinpoint regression gave annual and average annual percent changes (APCs, AAPCs). Results: Among 557,547 deaths, the overall AAMR rose from 29.50 per 100,000 in 1999 to 55.69 in 2023, peaking at 65.70 in 2020 (AAPC: 2.64; 95% CI: 0.93–4.39; p = 0.002). Men had a higher mean AAMR than women (57.58 vs. 47.29), but only women rose significantly (AAPC: 3.66; p < 0.001 vs. 1.42; p = 0.128); the male-to-female ratio fell from 1.62 to 0.97, with women overtaking men by 2023. The mean AAMRs were 55.07 in non-Hispanic (NH) White (AAPC: 3.02; p = 0.0004), 40.56 in NH Black (2.70; p = 0.035), 32.47 in Hispanic (1.20; p = 0.001), and 20.42 in NH Asian or Pacific Islander adults (3.13; p = 0.206); and 55.18 in the South (2.80; p < 0.001), 54.84 in the Midwest (3.02; p = 0.004), 51.19 in the West (2.53; p = 0.005), and 39.60 in the Northeast (1.91; p = 0.065). Non-metropolitan AAMRs exceeded metropolitan AAMRs (61.70 vs. 47.61; AAPC: 4.12; p < 0.001 vs. 2.85; p = 0.008), with the gap widening from 5.0 to 22.6. 2023 CMRs were 243.83 (≥ 85 years; AAPC: 3.19; p = 0.001), 59.36 (75–84; 2.38; p = 0.011) and 8.98 (65–74; 2.80; p = 0.019). Nursing home deaths fell from 58.2% to 43.3% as home deaths rose to 28.0% and hospice deaths to 7.9%. Conclusion: Mortality involving coexisting CLRD and dementia in older US adults nearly doubled from 1999 to 2023, shifting toward women, non-metropolitan residents, and the very old, while end-of-life care moved from hospitals and nursing homes into homes and hospices.
- 22 August 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 179 (2)
Trends and disparities in mortality due to secondary malignant neoplasm of the brain and cerebral meninges in the United States (1999–2024)
- 22 August 2026
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 179 (2)
Trends and disparities in mortality due to secondary malignant neoplasm of the brain and cerebral meninges in the United States (1999–2024)
- Open Access
- 13 August 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Temporal trends and demographic disparities in constipation-associated mortality in the United States, 1999–2024
- 13 August 2026
- Published by Springer Nature in BMC Gastroenterology
- Vol. 26 (1)
Open AccessTemporal trends and demographic disparities in constipation-associated mortality in the United States, 1999–2024
- Open Access
- 9 June 2026
- Published by Elsevier in SSRN Electronic Journal
National Trends in Mortality Involving Coronary Artery Disease and Depression in the United States, 1999–2025: A CDC WONDER Analysis
Background: Coronary artery disease (CAD) and depression frequently coexist and may synergistically worsen outcomes through behavioral, inflammatory, and neuroendocrine mechanisms. However, national mortality trends involving both conditions remain incompletely characterized.Objective: To evaluate temporal trends and demographic disparities in mortality involving CAD and depression in the United States from 1999–2025.Methods: We conducted a retrospective population-based study using the CDC WONDER Multiple Cause of Death database. Adults aged ≥25 years with ICD-10 codes for CAD (I20–I25) and depression (F32, F33, F41.2) listed anywhere on the death certificate were identified. Age-adjusted mortality rates (AAMRs) per 100,000 population were standardized to the 2000 U.S. population. Joinpoint regression was used to estimate annual percent change (APC) and average annual percent change (AAPC), with analyses stratified by age, sex, race/ethnicity, geographic region, urbanization, and state.Results: A total of 85,806 deaths were identified, with an overall average AAMR of 1.42. Mortality declined from 1.81 (95% CI, 1.75–1.87) in 1999 to 1.31 (95% CI, 1.26–1.35) in 2025 (AAPC, −1.38; p=0.002), although rates increased significantly between 2017 and 2020. Mortality was highest among older adults but increased among middle-aged adults (AAPC, 1.10; p<0.001). Males had higher mortality than females. The Midwest had the highest regional burden, while the South showed no significant overall improvement. Mortality increased among Black individuals after 2014 and remained higher in nonmetropolitan areas.Conclusions: Mortality involving CAD and depression declined overall but remained heterogeneous, with persistent racial and geographic disparities and rising mortality among middle-aged adults.
- 9 June 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessNational Trends in Mortality Involving Coronary Artery Disease and Depression in the United States, 1999–2025: A CDC WONDER Analysis
Background: Coronary artery disease (CAD) and depression frequently coexist and may synergistically worsen outcomes through behavioral, inflammatory, and neuroendocrine mechanisms. However, national mortality trends involving both conditions remain incompletely characterized.Objective: To evaluate temporal trends and demographic disparities in mortality involving CAD and depression in the United States from 1999–2025.Methods: We conducted a retrospective population-based study using the CDC WONDER Multiple Cause of Death database. Adults aged ≥25 years with ICD-10 codes for CAD (I20–I25) and depression (F32, F33, F41.2) listed anywhere on the death certificate were identified. Age-adjusted mortality rates (AAMRs) per 100,000 population were standardized to the 2000 U.S. population. Joinpoint regression was used to estimate annual percent change (APC) and average annual percent change (AAPC), with analyses stratified by age, sex, race/ethnicity, geographic region, urbanization, and state.Results: A total of 85,806 deaths were identified, with an overall average AAMR of 1.42. Mortality declined from 1.81 (95% CI, 1.75–1.87) in 1999 to 1.31 (95% CI, 1.26–1.35) in 2025 (AAPC, −1.38; p=0.002), although rates increased significantly between 2017 and 2020. Mortality was highest among older adults but increased among middle-aged adults (AAPC, 1.10; p<0.001). Males had higher mortality than females. The Midwest had the highest regional burden, while the South showed no significant overall improvement. Mortality increased among Black individuals after 2014 and remained higher in nonmetropolitan areas.Conclusions: Mortality involving CAD and depression declined overall but remained heterogeneous, with persistent racial and geographic disparities and rising mortality among middle-aged adults.